Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Advanced Cancer|Ovarian Cancer|Endometrial Cancer|Breast Cancer
Interventions: DRUG: PM01183 + olaparib
Sponsor: Poveda, Andrés, M.D.
Collaborators: AstraZeneca|PharmaMar